TOMI Environmental Solutions Secures UK Cleanroom System Order with Total Clean Air

Reuters
Jan 20
<a href="https://laohu8.com/S/TOMZ">TOMI Environmental</a> Solutions Secures UK Cleanroom System Order with Total <a href="https://laohu8.com/S/CLRMF">Clean Air</a>

TOMI Environmental Solutions Inc. announced the sale of a Custom Engineered System (CES) in the United Kingdom to an international pharmaceutical manufacturing organization. The CES integrates TOMI's SteraMist iHP technology into Total Clean Air's modular cleanroom platform. This deployment is part of TOMI's international growth strategy and is intended to provide pharmaceutical manufacturers with integrated, compliant decontamination solutions. The modular solution has been developed to align with UK MHRA and EMA expectations, embedding decontamination capability directly into the cleanroom lifecycle.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOMI Environmental Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9628674) on January 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10